Kitov Pharmaceuticals Seeks a Commercial Partner for their Phase 3 Lead Product KIT-302, a Combinati
Kitov Pharmaceuticals, based in Israel, announces their lead product KIT-302. It combines Celecoxib (a COX-2 selective NSAID, the active...
top of page
Sage Group News
bottom of page